Related Experiment Video
Updated: Dec 15, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway
1Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, 215004, Jiangsu Province, People's Republic of China.
Purpose:
Increasing evidence suggested that microRNA plays an important role in ovarian cancer. In this study, the role of miR-92 in ovarian cancer was investigated.
Methods:
In this study, miR-92 expression in clinical sample was evaluated, role of miR-92 was investigated in vitro, and underlying mechanism was investigated using Chip, co-IP, and western blot.
Results:
In this study, we show that miR-92 is overexpressed in ovarian cancer tissue compared with normal cancer tissue. Transfection of miR-92 increased proliferation of ovarian cancer cell, and increased migration capacity and colony formation were observed after miR-92 transfection; we found that expression of LATS2 was decreased by miR-92, and this was further confirmed by luciferase assay, which proved that miR-92 is targeting 3' of the endogenous LATS2 gene. Downregulation of LATS2 resulted in increased translocation of YAP1 and upregulation of PD-L1, which subsequently suppressed NK cell function and promoted T cell apoptosis. Moreover, co-transfection of YAP1-targeted shRNA could relieve miR-92-induced immune suppression effect. Mechanically, immunoprecipitation (IP) was used to show that LATS2 interacted with YAP1 and subsequently limited nuclear translocation of YAP1; chromatin immunoprecipitation (ChIP) was used to confirm that YAP1 could bind to enhancer region of PD-L1 to enhance transcription activity of PD-L1.
Conclusions:
Our data revealed a novel mechanism which finally resulted in immune suppression in ovarian cancer.
Insights
MicroRNA-92 (miR-92) is overexpressed in ovarian cancer, promoting tumor growth and immune suppression by targeting LATS2, leading to increased PD-L1 and reduced NK cell function.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- MicroRNAs (miRNAs) are critical regulators in various cancers, including ovarian cancer.
- Dysregulation of miRNA expression is implicated in ovarian cancer pathogenesis and progression.
Purpose of the Study:
- To investigate the role of microRNA-92 (miR-92) in ovarian cancer.
- To elucidate the underlying molecular mechanisms by which miR-92 influences ovarian cancer progression and immune evasion.
Main Methods:
- Quantitative analysis of miR-92 expression in clinical ovarian cancer tissues.
- In vitro functional assays to assess the impact of miR-92 on cancer cell proliferation, migration, and colony formation.
- Molecular mechanism studies using luciferase assays, co-immunoprecipitation (Co-IP), and chromatin immunoprecipitation (ChIP) to identify miR-92 targets and downstream pathways.
Main Results:
- miR-92 is significantly overexpressed in ovarian cancer tissues compared to normal tissues.
- miR-92 promotes ovarian cancer cell proliferation, migration, and colony formation.
- miR-92 directly targets LATS2, leading to its downregulation.
- Downregulation of LATS2 results in YAP1 translocation, PD-L1 upregulation, and subsequent suppression of Natural Killer (NK) cell function and promotion of T cell apoptosis.
- YAP1 binds to the enhancer region of PD-L1, enhancing its transcription.
Conclusions:
- miR-92 plays a crucial oncogenic role in ovarian cancer.
- A novel mechanism involving miR-92, LATS2, YAP1, and PD-L1 contributes to immune suppression in ovarian cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

